Audio

Community Oncology Podcast - Vismodegib for advanced basal cell carcinomas

Publish date: February 28, 2013

 

Community Oncology's podcasts by Editor in Chief Dr. David Henry features an update on vismodegib for advanced basal cell carcinoma and a rapid desensitization regimen for patients with hypersensitivity reactions to platinum compounds and taxanes.

Recommended Reading

More Evidence Links Tanning Beds to Skin Cancer
MDedge Hematology and Oncology
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
MDedge Hematology and Oncology
Imaging Unwarranted in Primary Cutaneous Melanoma
MDedge Hematology and Oncology
Tuberous Sclerosis Skin Lesions Improved on Everolimus
MDedge Hematology and Oncology
Merkel Cell Carcinoma Prognosis Linked to Vitamin D
MDedge Hematology and Oncology
Melanoma Treatment With Vemurafenib Can Trigger Leukemia
MDedge Hematology and Oncology
Cancer deaths declined 20% since 1991
MDedge Hematology and Oncology
In Europe, melanoma is rising in men over 60
MDedge Hematology and Oncology
Community Oncology Podcast - Everolimus for tuberous sclerosis
MDedge Hematology and Oncology
Vismodegib in advanced basal cell carcinoma
MDedge Hematology and Oncology